Innovative Vaccine Investment ISA will help save children's lives

World Bank acting as its Treasury Manager and managing IFFIm’s finances, IFFIm has raised more than US$1.6 billion to support GAVI immunisation programmes since 2006. IFFIm has triple-A rating due to the support of seven governments led by the UK, who have pledged to contribute money over 20 years.

Not for distribution in the United States, Australia, Canada or JapanThe proceeds of these pledges are used, among other things, to repay the initial investments plus the fixed return.Stephen Green, Group Chairman of HSBC said: “We are proud to be able to offer this innovative investment opportunity while also supporting a most worthwhile humanitarian cause. By raising funds for GAVI’s immunisation programmes through IFFIm, we will be helping to save and protect a large number of lives in the poorest countries of the world.International Development Secretary of the UK, Douglas Alexander said: "The economic downturn could push millions of people into extreme poverty and cause the deaths of up to 2.8 million children. Innovative initiatives like this are vital if we are to prevent this financial crisis from becoming a human crisis. That is why Gordon Brown is leading a new Taskforce on Innovative International Financing for Health Systems, to help save the lives of many millions more."Financial Secretary to the Treasury, Stephen Timms MP said: "I am pleased we have been able to ensure that IFFIm bonds can be made available through an ISA. This will enable investors looking for ethical returns to benefit from the tax advantages of ISAs and increase funding for life saving vaccines in developing countries. I congratulate all involved in this initiative"The Vaccine Investment Plan and Vaccine Investment ISA are the first initiatives of their kind in the UK to raise funds from personal investors and pay them a competitive return for their funds whilst protecting children in the world’s poorest countries from life-threatening diseases.The Vaccine Investment Plan and Vaccine Investment ISA will be available through HSBC on a non advised basis from 2 March to 24 April. For more information go to hsbc.co.uk/vaccine, or call HSBC on 0800 328 1293, visit any HSBC branch for a full application pack.These materials are not an offer for sale of securities. The securities referred to herein have not been registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and may not beNot for distribution in the United States, Australia, Canada or Japan offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act. The issuer does not intend to register any part of the offering in the United States or to offer or sell any of the securities in the United States.The Vaccine Investment Plan and Vaccine Investment ISA are offered by HSBC Trust Company (UK) Limited. Authorised and regulated by the Financial Services Authority.